scholarly journals Enhancing Inflammation Targeting Using Tunable Leukocyte-Based Biomimetic Nanoparticles

ACS Nano ◽  
2021 ◽  
Author(s):  
Assaf Zinger ◽  
Manuela Sushnitha ◽  
Tomoyuki Naoi ◽  
Gherardo Baudo ◽  
Enrica De Rosa ◽  
...  

2018 ◽  
Vol 8 (1) ◽  
pp. 23-33 ◽  
Author(s):  
Kai Jin ◽  
Zimiao Luo ◽  
Bo Zhang ◽  
Zhiqing Pang


Small ◽  
2021 ◽  
pp. 2006484
Author(s):  
Fatemeh Oroojalian ◽  
Mohammad Beygi ◽  
Behzad Baradaran ◽  
Ahad Mokhtarzadeh ◽  
Mohammad‐Ali Shahbazi


Cell Cycle ◽  
2010 ◽  
Vol 9 (13) ◽  
pp. 2481-2482 ◽  
Author(s):  
Noula Shembade ◽  
Edward Harhaj


2020 ◽  
Author(s):  
Dan Liu ◽  
Jiale Liu ◽  
Bing Ma ◽  
Bo Deng ◽  
Haiyan Xu ◽  
...  

Abstract Background: Biomimetic nanoparticles have potential applications in many fields for their favorable properties. Results: Here, we developed a self-adjuvanting biomimetic anti-tumor nanovaccine, which was self-assembled with an amphiphilic conjugate synthetized with phospholipids of 1, 2-Dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) and hydrophilic Toll-like receptor (TLR9) agonists CpG ODN. The nanovaccine could not only provide effective initial antigens stimulation and sustained long-term antigen supply with a controlled release, but also induce antigens cross-presentation via MHC-I pathway initiating CD8+ T-cell responses. Moreover, the dense nucleotides shell around the nanovaccine could promote antigens endocytosis via various receptor-mediated pathways into dendritic cells. And CpG ODN interacted with TLR9 triggering the cytokines secretion of TNF-α and IL-10 further boosted the anti-tumor humoral and cellular immune responses, which led to significant tumor suppressive effect and remarkable survival prolongation. Conclusions: So, this nanovaccine self-assembled with phospholipid-nucleotide amphiphiles can serve as a safe, simple and efficient approach for anti-tumor immunotherapy.



2020 ◽  
Vol 34 (S1) ◽  
pp. 1-1
Author(s):  
Katyayani Tatiparti ◽  
Mohd Ahmar Rauf ◽  
Samaresh Sau ◽  
R. Alzhrani ◽  
Arun Iyer


2021 ◽  
pp. 114006
Author(s):  
Nishta Krishnan ◽  
Ronnie H. Fang ◽  
Liangfang Zhang


2020 ◽  
Vol 7 (4) ◽  
pp. 349-358
Author(s):  
Long Yang ◽  
Guangchao Zang ◽  
Jingwen Li ◽  
Xinyue Li ◽  
Yuanzhu Li ◽  
...  

Abstract Atherosclerosis is a key mechanism underlying the pathogenesis of cardiovascular disease, which is associated with high morbidity and mortality. In the field of precision medicine for the treatment of atherosclerosis, nanoparticle (NP)-mediated drug delivery systems have great potential, owing to their ability to release treatment locally. Cell-derived biomimetic NPs have attracted extensive attention at present due to their excellent targeting to atherosclerotic inflammatory sites, low immunogenicity and long blood circulation time. Here, we review the utility of cell-derived biomimetic NPs, including whole cells, cell membranes and extracellular vesicles, in the treatment of atherosclerosis.



Nanoscale ◽  
2019 ◽  
Vol 11 (42) ◽  
pp. 20206-20220 ◽  
Author(s):  
Shulan Han ◽  
Wenjie Wang ◽  
Shengfang Wang ◽  
Shuo Wang ◽  
Ruijun Ju ◽  
...  

Immunosuppression and immune tolerance lead tumor cells to evade immune system surveillance and weaken drug efficacy.



Sign in / Sign up

Export Citation Format

Share Document